Multicenter study on the effectiveness of atrial fibrillation ablation in secondary prevention of cardiogenic cerebral embolism and systemic embolism.

Multicenter study on the effectiveness of atrial fibrillation ablation in secondary prevention of cardiogenic cerebral embolism and systemic embolism. - Study on the effect of atrial fibrillation ablation in secondary prevention of cardiogenic cerebral embolism.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026074

Enrollment

500

Registered

2017-02-10

Start date

2017-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation Cerebral infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with past history of cardiogenic (cerebral, systemic) embolism due to atrial fibrillation and indication for pulmonary venous isolation as a treatment for atrial fibrillation

Exclusion criteria

Exclusion criteria: Patients who have the severe sequela of cerebral embolism to such an extent that it is difficult to safely perform pulmonary artery isolation and patients who are deemed inappropriate by the attending physician due to other complications or clinical course

Design outcomes

Primary

Measure	Time frame
Recurrence of cardiogenic cerebral embolism and systemic embolism.	—

Countries

Japan

Contacts

Public ContactKenichi Iijima

Niigata University Graduate School of Medical and Dental Sciences Department of Cardiovascular Biology and Medicine

kenichi@mad.niigata-u.ac.jp025-227-2185

Outcome results